Genmab A/S
CSE:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
CSE:GMAB
|
DK |
|
Eurotech SpA
MIL:ETH
|
IT |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
Ford Otomotiv Sanayi AS
IST:FROTO.E
|
TR |
|
Exodus Movement Inc
OTC:EXOD
|
US |
|
China Resources Cement Holdings Ltd
HKEX:1313
|
HK |
|
Domtar Corp
TSX:UFS
|
US |
|
QBE Insurance Group Ltd
ASX:QBE
|
AU |
|
P
|
Power Root Bhd
KLSE:PWROOT
|
MY |
|
F
|
FinecoBank Banca Fineco SpA
OTC:FCBBF
|
IT |
|
Bang & Olufsen A/S
CSE:BO
|
DK |
|
KG Intelligence Co Ltd
TSE:2408
|
JP |
|
Globex Mining Enterprises Inc
TSX:GMX
|
CA |
|
AES Corp
NYSE:AES
|
US |
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
Ocean Wilsons Holdings Ltd
LSE:OCN
|
BM |
|
National Fertilizers Ltd
NSE:NFL
|
IN |
|
Quantum Secure Encryption Corp
OTC:QSEGF
|
CA |
|
AGC Inc
TSE:5201
|
JP |
|
H
|
H & M Hennes & Mauritz AB
XMUN:HMSB
|
SE |
|
Eastern International Ltd
NASDAQ:ELOG
|
CN |
|
G
|
Global-Dining Inc
TSE:7625
|
JP |
|
Thermador Groupe SA
PAR:THEP
|
FR |
|
H
|
HocMon Trade JSC
VN:HTC
|
VN |
Wall Street
Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for
GMAB
is 2 283.78 DKK
with a low forecast of 1 313 DKK and a high forecast of 3 167.85 DKK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMAB's stock price target?
Price Target
2 283.78
DKK
According to Wall Street analysts, the average 1-year price target for
GMAB
is 2 283.78 DKK
with a low forecast of 1 313 DKK and a high forecast of 3 167.85 DKK.
What is Genmab A/S's Revenue forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
Genmab A/S's revenue is
33%.
The projected
CAGR
for the next 3 years is
17%.
What is Genmab A/S's Operating Income forecast?
Projected CAGR
18%
The
compound annual growth rate
of Genmab A/S's operating income for the next 3 years is
18%.
What is Genmab A/S's Net Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Genmab A/S's net income for the next 3 years is
23%.
